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ABSTRACT
Background: Dendritic cells (DC) determine initiation, type and location of 
immune responses and, in adults, show decreased Toll-like receptors and some 
increased cytokine levels on ageing. Few studies in children have characterised DC 
or explored DC-related mechanisms producing age-related immune changes.
Methods: Blood and colonic DC phenotypes were determined in healthy adults 
and children by flow cytometry and correlated with aging. Blood DC were divided 
into plasmacytoid (pDC) and myeloid (mDC) while only mDC were identified in colon. 
Serum cytokine levels were determined by multiplex cytokine assays and correlated 
with DC properties. 
Results: The pDC marker BDCA2 (but not CD123) was absent in pre-pubertal 
children and numbers of pDC decreased with age. Blood and colonic DC were more 
mature and activated in adults. Decrease in pDC numbers correlated with reduced 
GM-CSF levels with aging, but increasing IL-4 and IL-8 levels correlated with a more 
activated DC profile in blood. CXCL16 levels decreased with age.
Conclusions: In children, lack of BDCA2, a receptor mediating antigen capture 
and inhibiting interferon induction, may be immunologically beneficial during immune 
development. Conversely, reduced pDC numbers, probably secondary to decreasing 
GM-CSF and increasing cytokine-induced maturation of DC are likely to determine 
deteriorating immunity with ageing.
INTRODUCTION
Dendritic cells (DC) are central to the initiation 
of primary immune responses. They are the most potent 
antigen-presenting cells capable of stimulating naïve 
T cells and hence they are pivotal in the generation and 
control of adaptive immunity serving as a link between 
the innate and adaptive immune system [1]. DC can be 
subdivided into myeloid (mDC) and plasmacytoid (pDC). 
mDC capture antigens in the periphery and then migrate 
to the lymphoid organs to initiate immunity, whereas pDC 
are found in the thymic medulla and lymph node T cell 
areas and contribute to anti-viral responses [2].
Few studies have characterised DC in children 
usually with contradictory results [3-6]. However, studies 
examining different DC subsets showed that numbers of 
circulating pDC (but not mDC) are inversely correlated 
with age [6-8] while the phenotype and antigen presenting 
capacity of circulating and monocyte-derived DC is not 
affected with age [9]. Nevertheless, a recent study has 
described specific changes in the activation of the AKT 
kinase pathway resulted in an impaired migration capacity, 
decreased ability to uptake and process antigens and 
increased cytokine production by mDC in aged subjects 
[10-12]. Therefore, given the lack of studies addressing 
age-related effect on DC properties, here we have 
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characterized blood and colonic DC in healthy children 
and adults to investigate age-related changes. 
RESULTS
Characterization of human blood and colonic DC
Total DC were identified within single viable 
PBMC (based on the forward/side scatter properties of the 
cells) that were HLA-DR+lineage (CD3, CD14, CD16, 
CD19, CD34)- as previously described [13, 14]. DC were 
subsequently divided into mDC (CD11c+CD123-) and 
pDC (CD11c-CD123+) (Figure 1A). 
The proportion (relative to total PBMC) and 
absolute numbers of mDC were not affected by the age 
of the donor (Figure 1B). However, both proportion (r = 
0.93, p < 0.0001) and absolute numbers (r = 0.97, p < 
0.0001) of pDC decreased with age (Figure 1C). 
Colonic DC were identified within single viable 
LPMC (based on the forward/side scatter properties 
of the cells) as leukocytes (CD45+) which were HLA-
DR+lineage-. Only CD11c+ mDC were identified within 
colonic DC (Figure 1D) and their frequency was not 
affected by the age of the donor (Figure 1E). 
BDCA2 (CD303) is absent on blood pDC in pre 
pubertal children
Having confirmed that blood pDC levels were 
affected by age (Figure 1C), we next determined if 
expression of the markers typically used to identify them 
(i.e. CD123 and BDCA2) were also affected by the age 
of the donor. The expression of CD123 was unaffected 
by the age (Figure 2A) when determined as the mean 
fluorescence index (MFI, r = -0.20, p = 0.52) (Figure 
2B). However, BDCA2 expression was absent on CD11c-
CD123+ pDC from pre pubertal pediatric patients (Figure 
2A) with its expression displaying a positive correlation (r 
= 0.71, p = 0.009) with the age of the donor (Figure 2B).
Blood DC immunophenotyping
Since both circulating pDC numbers and their 
BDCA2 expression are influenced by the age of the donor, 
we next characterised DC phenotype in both healthy adults 
and children to identify other potential markers which 
may be age-influenced. Blood mDC and pDC were thus 
characterized for the expression of the mucosal (Integrin 
beta-7; β7), skin (Cutaneous lymphocyte antigen; CLA), 
lymph-node (C-C chemokine receptor; CCR7) and small 
bowel (C-C chemokine receptor 9; CCR9) homing 
markers, together with their activation status (CD40 and 
CD86) and expression of pattern recognition receptors 
(Toll-like receptors (TLR)2 and 4) (Figure 3). Blood 
mDC (Figure 3A and 3B) and pDC (Figure 3C and 3D) 
from the adult population were more mature (higher CD40 
and CD86 expression) with higher small bowel homing 
capacity (CCR9). Additionally, adult pDC had lower 
lymph-node homing capacity (lower expression of CCR7) 
and higher potential capacity to recognize microbial 
antigens (higher levels of TLR2) (Figure 3C and 3D). 
Colonic DC characterization
We next studied whether the age-related properties 
of circulating DC were also reflected in other tissues so 
human colonic DC were also characterized. In agreement 
with observations of blood mDC and pDC, colonic 
DC from the same donors were more mature (CD40 
and CD86) in the adult population (Figure 4A and 4B) 
confirming a lower activation status of circulating and 
colonic DC in the pediatric population. 
Blood cytokines and chemokines
Next, we studied the potential mechanisms that 
may account for changes in DC phenotype with aging by 
determining serum concentration of several cytokines and 
chemokines. Our results revealed that the adult population 
had higher serum levels of IL-4 and IL-8 coupled with 
lower levels of CXCL16 and GM-CSF while 36 other 
soluble mediators remained unchanged with age (Table 1). 
Finally, we determined whether such differences 
in cytokine/chemokine levels correlated with age-
related changes in DC phenotype (Table 2). The lower 
levels of pDC with aging correlated with GM-CSF 
concentration and inversely correlated with IL-4 and IL-8 
concentrations. BDCA2 MFI on pDC, on the contrary, 
displayed a positive correlation withIL-4 and IL-8 levels. 
CD40 on pDC and TLR2 expression on mDC correlated 
with IL-4 and IL-8 concentrations while CD86 correlated 
with IL-8 concentrations and inversely with GM-CSF 
levels. Changes in CCR7 expression on mDC correlated 
with IL-4 and IL-8 levels and inversely with GM-CSF and 
CXCL16 levels. CCR7 expression on pDC correlated with 
GM-CSF levels. CCR9 expression correlated with IL-4 
and IL-8 levels. β7 and CLA did not correlate with any 
of the cytokine or chemokine levels. As for colonic DC, 
CD40 expression correlated inversely with GM-CSF. The 
rest of the DC phenotypic markers did not correlate with 
any cytokine or chemokine levels. Together the evidence 
suggested that the circulating levels of IL-4, IL-8 and 
GM-CSF are the main soluble factors influencing the age-
related properties of blood and colonic DC (Table 2).
DISCUSSION
Here we show that expression of BDCA2 (CD303) 
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Figure 1: Blood and colonic DC identification. A. Forward and side scatter plot of peripheral blood mononuclear cells (PBMC) and 
subsequent doublet discrimination. Blood dendritic cells (DC) were identified as HLA-DR+lineage- (CD3,CD14,CD16,CD19,CD34) and 
further divided into myeloid (CD11c+,mDC) and plasmacytoid (CD123+,pDC). B. Percentage and absolute numbers of mDC and C. pDC 
were correlated with the age of the donors. D. Colonic DC were identified with singlet viable lamina propria mononuclear cells (LPMC) 
based on the forward and side scatter properties of the cells and identified within CD45+ cells as HLA-DR+lineage-CD11c+. E. Percentage of 
colonic DC (referred to total LPMC) were also correlated with the age of the donor. Pearson´s correlation analysis and p-value is displayed. 
P<0.05 was considered as statistically significant.
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only appears on blood pDC at around the age of puberty. 
In addition, a decrease in blood pDC numbers with age 
coupled with general increases in maturation status of both 
colonic and blood pDC and mDC is also described. The 
findings suggest that the DC populations provide evidence 
both of maturation of the immune system in young 
children as well as supporting the view that aging in older 
people is a process of general deterioration of immunity; 
development of an on-going low-grade inflammation 
may be an underlying cause of mortality and age-related 
diseases [15]. 
BDCA2 is commonly used as a pDC marker so that 
its absence in pre-pubertal children might lead to practical 
problems of pDC identification in the pediatric populations 
when using this marker instead of CD123. However, 
functional changes related to lack of BDCA2 may be more 
significant; BDCA2 signalling leads to reduced levels of 
transcripts for type-1 interferon genes [16] suggesting 
that production of such cytokines could be increased in 
pDC during childhood. Therefore, the lack of BDCA2 on 
pDC during childhood could have beneficial effects given 
that children have high propensity for viral infections so 
need this enhanced ability to make innate IFN due to lack 
of T cell memory. However, these potential functional 
differences between adult and pediatric pDC warrant 
further study which are limited by ethical considerations 
when studying healthy children. The mechanisms 
responsible for aging-related chronic inflammation are 
also not well understood. Here, we provide some bases for 
deteriorating immunity by describing a specific reduction 
of circulating pDC with age coupled with an increased 
maturation status of both blood and colonic DC.
Blood pDC numbers decreased with age suggesting 
a partial dysregulation of circulating DC. There was also 
an increased expression of TLR2 on pDC and increased 
expression of CD40 and CD86 in both mDC and pDC 
suggesting an increase in the general activation profile of 
DC with aging. Reports on young and aged adults have 
not shown similar increases in activation profile [17]. 
However, there was no comparison of DC in children 
and adults which was the focus of our study. There is 
reduced expression of TLR1,3,7,8 in aged individuals 
when compared with young adults [18, 19] and increased 
production of pro-inflammatory cytokines (IL-6 and IL-
18) and lower amounts of anti-inflammatory mediators 
including IL-10 with aging in adults [17, 20, 21]. The 
studies in the literature thus support our findings that 
aging does result in a more pro-inflammatory DC profile. 
In addition,, the increased maturation status of DC was not 
restricted to blood pDC but was also found on blood mDC 
and colonic DC which suggests a more systemic activation 
in both blood and tissues. 
In order to gain insights into possible mechanism 
at play in the development of DC changes with age we 
studied serum levels of 40 cytokines/chemokines. IL-4 
and IL-8 displayed a positive correlation with aging as 
opposed to CXCL16 and GM-CSF which displayed a 
negative correlation. The increase of IL-4 and IL-8 with 
Figure 2: BDCA2 is absent on pediatric blood pDC. A. Blood myeloid (mDC) and plasmacytoid (pDC) dendritic cells were 
identified as in Figure 1A and backgated for the analysis of BDCA2 (CD303) in a 12 year old, a 15 year old and a 42 year old adult 
healthy control. Pooled data is shown in B. Pearson´s correlation analysis and p-value is displayed. P < 0.05 was considered as statistically 
significant. 
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Figure 3: Blood DC changes with the age. A. Blood myeloid dendritic cells (mDC) were identified as in Figure 1A and characterized 
for the expression of several markers in a representative healthy children and a healthy adult. Pooled data and correlation with the age 
of the donor is shown in B. C. Blood plasmacytoid dendritic cells (pDC) were also identified as in Figure 1A and characterized for the 
expression of several markers in a representative healthy children and a healthy adult. Pooled data and correlation with the age of the donor 
is shown in D. In all cases, the expression of each individual marker is shown as percentage (%). Pearson´s correlation analysis and p-value 
is displayed. P < 0.05 was considered as statistically significant. 
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age is in keeping with previously published literature [17, 
22] suggesting that the general body milieu becomes more 
pro-inflammatory with age. Indeed, IL-4 and IL-8 were the 
cytokines which displayed the biggest correlation with the 
age of the donor (Table 1) and correlated with most of the 
age-induced changes of DC properties (Table 2) including 
the lower numbers of circulating pDC with aging and the 
lack of BDCA2 expression of pre-pubertal circulating 
pDC suggesting they are the main cytokines influencing 
the age-related changes displayed by DC. However, adult 
mDC and pDC from healthy adult volunteers (mean age 
38.7±4.2 years) did not alter the expression of any of the 
studied markers following short term in vitro stimulation 
with IL-4, IL-8 or GM-CSF (data not shown) suggesting 
that such changes may be initiated at a younger stage or 
require more persistent exposure.
In contrast to IL-4 and IL-8, which displayed a 
positive correlation with age, GM-CSF showed a negative 
correlation with age. GM-CSF is used to promote 
monocyte differentiation in vitro into monocyte-derived 
DC (MoDC) [23-26]. Given that lower pDC numbers with 
aging also correlated with lower levels of GM-CSF, GM-
CSF might affect circulating pDC levels. Finally, CXCL16 
was significantly higher in children. CXCL16 is an age 
and organ-dependent chemokine regulated by microbial 
exposure during early life [27]; lower levels of bacterial 
exposure during early life correlate with higher levels of 
CXCL16 [28, 29]. The high CXCL16 in children might be 
in keeping with increased antibiotic exposure of children 
in the current era. However the age-related changes on 
CXCL16 were borderline (Table1) so we cannot conclude 
that there is a direct influence. 
In summary, we have described age-related changes 
to blood and colonic DC numbers and phenotype, 
particularly acquisition of the marker BDCA-2 and 
reduced numbers of circulating pDC with age. It will 
be important to determine how these changes in DC 
phenotype affect their function during our lifetime. The 
results showing lower BDCA2 on pDC in children could 
also be a basis for age-related functional differences in 
responsiveness to interferons in children. 
MATERIALS AND METHODS
Blood and colonic tissue samples
Blood samples and distal colonic biopsies were 
obtained from 8 children (age range 6-15 years, 6 
males) while undergoing colonoscopy for painless rectal 
bleeding for suspected benign polyp. The endoscopies 
were macroscopically and histologically normal apart 
from 3 patients showing isolated rectal polyps. All the 
children were recruited over a 2 year period in a pediatric 
gastroenterology department at Chelsea & Westminster 
Figure 4: Colonic DC changes with the age. A. Colonic dendritic cells (DC) were identified as in Figure 1D and characterized for the 
expression of several markers in a representative healthy children and a healthy adult. Pooled data and correlation with the age of the donor 
is shown in B. Pearson´s correlation analysis and p-value is displayed. P < 0.05 was considered as statistically significant.
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Table 1: Cytokine levels in the plasma
Cytokines              Children
Cytokine concentration pg/ml
               Adults           
 Cytokine concentration pg/ml r-value p-value
     Mean Standard deviation Mean Standard deviation
CCL1 12.95 1.44 13.16 0.63 0.18 0.62
CCL11 12.36 4.18 14.28 3.01 0.23 0.49
CCL15 1194 386.8 2615 1756 0.64 0.12
CCL17 13.45 6.21 12.69 13.34 -0.15 0.76
CCL19 10.44 4.66 11.36 9.60 0.08 0.84
CCL20 2.56 0.43 3.07 1.50 0.31 0.37
CCL21 614.1 259.9 531.4 290.2 -0.17 0.62
CCL24 4.89 2.33 9.63 6.48 0.48 0.18
CCL25 62 13.99 64.10 18.90 0.14 0.71
CCL26 20.21 11.79 14.31 6.62 -0.34 0.36
CCL27 51.22 33.74 36.75 20.66 -0.33 0.38
CX3CL1 23.13 10.58 18.91 7.01 -0.27 0.40
CXCL1 32.24 13.03 32.66 7.27 0.05 0.90
CXCL12 76.88 29.16 152.2 69.46 0.56 0.11
CXCL13 2.19 0.43 1.91 1.20 -0.12 0.75
CXCL16 161.2 51.70 105.2 22.30 -0.62 0.05
CXCL2 13.83 4.10 18.06 3.26 0.52 0.17
CXCL5 96.4 31.09 55.98 9.68 -0.72 0.10
CXCL6 5.13 1.71 4.13 0.56 -0.35 0.48
GM-CSF 31.65 8.46 9.08 11.95 -0.74 0.01
IFN gamma *** ***
IL-10 2.77 1.31 2.62 0.62 -0.01 0.96
IL-16 194.8 66.78 174.1 104.8 -0.04 0.91
IL-1Beta 0.11 0.08 0.13 0.06 0.05 0.91
IL-2 5.81 1.44 4.76 0.72 -0.39 0.25
IL-4 1.10 0.53 2.91 1.28 0.79 0.005
IL-6 4.13 3.79 1.08 0.43 -0.56 0.09
IL-8 1.39 1.05 9.92 7.93 0.69 0.01
IP10 5.18 4.26 11.1 6.54 0.48 0.18
ITAC 9.80 5.32 8.79 6.57 -0.16 0.66
MCP1 8.97 7.07 4.85 1.97 -0.32 0.33
MCP2 3.93 3.26 7.18 4.03 0.46 0.17
MCP3 9.46 1.97 14.77 5.13 0.54 0.20
MCP4 9.45 3.19 18.34 12.25 0.41 0.30
MDC 93.88 25.67 108.5 35.19 0.25 0.47
MIF 116.7 87.68 46.11 42.62 -0.42 0.22
MIG 32.26 10.75 22.23 15.35 -0.42 0.24
MIP1alpha 0.95 0.61 0.61 0.28 -0.31 0.44
MPIF1 28.84 10.37 49.82 30.03 0.54 0.10
TNF Alpha 3.44 1.39 3.39 1.17 -0.02 0.94
Statistically significant differences for each cytokine/chemokine after Pearson´s correlation analysis with the age are shown 
in bold italics
***= below detection limit,   pg/ml=picograms/millilitre
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Hospital (London, UK). 
Blood and distal colonic biopsies were also obtained 
form 10 adults (Age range 19- 52 years, 4 males) when 
undergoing endoscopy for change in bowel habit from 
an adult gastroenterology centre at St Mark’s Hospital 
(London, UK). The endoscopies were macroscopically and 
histologically normal in all the 10 patients. 
Informed consent was obtained from all 
patients/parents/legal guardians and the protocol was 
approved by the National Research ethics committee 
and the local research and development committee. 
The exclusion criteria were: diagnosed or suspected 
chromosomal abnormality, major medical illness or 
immunocompromised states.
Blood dendritic cells
Serum samples were immediately frozen at 
-80ºC following blood extraction. Peripheral blood 
mononuclear cells (PBMC) were subsequently obtained 
by centrifugation of 10 ml of human peripheral blood over 
Ficoll Paque Plus (GE Healthcare, UK) at 800g, for 30 
minutes at room temperature and harvesting the buffy coat 
layer from the interface. The PBMC were washed twice 
(centrifugation 650g, 10 minutes and 450g, 5 minutes) in 
RPMI 1640 Dutch modification (Sigma-Aldrich, Dorset, 
England). 
Table 2 : Blood cytokines and chemokines correlation with DC markers
DC numbers 
&markers
Cytokines
IL-4 IL-8 GM-CSF CXCL16
r-value p-value r-value p-value r-value p-value r-value p-value
Blood mDC% 0.03 0.92 0.24 0.26 -0.35 0.31 -0.5 0.1
Blood pDC % -0.7 0.02 -0.69 0.01 0.80 0.004 0.41 0.23
Colon mDC% -0.14 0.68 -0.47 0.13 0.32 0.36 0.21 0.54
Blood mDC 
absolute numbers -0.3 0.29 -0.1 0.69 -0.08 0.81 0.05 0.87
Blood pDC absolute 
numbers -0.83 0.002 -0.71 0.01 0.65 0.03 0.03 0.94
CD123 MFI pDC 0.11 0.8 -0.07 0.87 -0.04 0.9 -0.5 0.3
BDCA2 MFI pDC 0.96 0.0005 0.87 0.0009 -0.7 0.12 -0.21 0.68
Beta7 blood mDC 0.61 0.07 0.36 0.27 -0.07 0.83 -0.52 0.11
Beta7 blood pDC 0.05 0.87 0.6 0.07 -0.2 0.53 0.4 0.24
Beta7 colon mDC 0.06 0.9 -0.73 0.5 -0.67 0.14 0.2 0.73
CLA blood mDC 0.36 0.3 0.07 0.82 0.5 0.13 -0.3 0.39
CLA blood pDC -0.13 0.7 -0.11 0.72 0.2 0.57 -0.02 0.95
CLA colon mDC 0.46 0.42 0.59 0.21 -0.71 0.11 0.36 0.54
CD40 blood mDC 0.48 0.15 0.5 0.11 -0.16 0.64 -0.09 0.78
CD40 blood pDC 0.73 0.01 0.98 0.0001 -0.05 0.13 -0.37 0.28
CD40 colon mDC -0.65 0.22 -0.38 0.44 -0.79 0.05 -0.13 0.83
CD86 blood mDC 0.26 0.45 0.55 0.07 -0.45 0.18 -0.19 0.59
CD86 blood pDC 0.41 0.23 0.69 0.01 -0.69 0.02 -0.45 0.18
CD86 colon mDC -0.72 0.16 -0.35 0.49 -0.71 0.09 -0.13 0.83
TLR2 blood mDC 0.72 0.01 0.79 0.003 -0.32 0.36 -0.15 0.66
TLR2 blood pDC 0.85 0.001 0.81 0.002 -0.37 0.28 -0.45 0.18
TLR2 colon mDC -0.48 0.40 -0.45 0.36 -0.49 0.31 -0.08 0.89
TLR4 blood mDC -0.12 0.72 -0.15 0.64 0.33 0.34 0.59 0.07
TLR4 blood pDC 0.19 0.58 0.38 0.23 -0.22 0.53 0.0008 0.99
TLR4 colon mDC -0.28 0.64 -0.39 0.43 -0.51 0.29 -0.13 0.83
CCR7 blood mDC 0.65 0.04 0.69 0.01 -0.84 0.001 -0.63 0.04
CCR7 blood pDC -0.25 0.47 -0.30 0.35 0.68 0.02 0.57 0.08
CCR7 colon mDC 0.28 0.63 0.07 0.89 -0.56 0.23 0.21 0.72
CCR9 blood mDC 0.85 0.001 0.57 0.06 -0.40 0.24 -0.35 0.31
CCR9 blood pDC 0.82 0.003 0.83 0.001 -0.36 0.29 -0.55 0.09
CCR9 colon mDC -0.05 0.92 0.20 0.69 -0.32 0.53 -0.38 0.51
Statistically significant differences for each DC parameter after Pearson´s correlation analysis with IL-4, IL-8, GM-CSF 
and CXCL16 concentration are shown in bold italics.
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Colonic biopsies
Five colonic mucosal biopsy specimens from the 
distal colon were taken per patient. Biopsy specimens 
were collected in ice-chilled complete medium (RPMI 
1640 Dutch modification supplemented with 10% fetal 
calf serum, 2mM L-glutamine, 25 µg/mL gentamicin 
and 100 U/mL penicillin/streptomycin) and processed 
within an hour. Mucus and faeces were removed from the 
biopsies using 1 mmol/L dithiothreitol (Sigma-Aldrich) 
in Hank’s balanced salt solution (Gibco BRL, Paisley, 
Scotland) for 20 minutes in T25 flasks. The epithelium was 
removed using two 30-minute treatments with 1 mmol/L 
EDTA in calcium- and magnesium-free Hank’s balanced 
salt solution at 37°C with gentle agitation. The biopsy 
specimens were cultured (1 biopsy per well in 1ml of 
complete medium) in a CO2 incubator (BioHit- 37°c, 5% 
CO2, high humidity) for 24 hours as previously described 
(14). Lamina propria mononuclear cells (LPMC) released 
from the tissue samples were passed through a 100μm 
cell strainer and washed twice with complete medium 
(Centrifugation at 600g, 5 minutes). 
Antibody labelling and flow cytometry
A minimum of 100,000 PBMC or LPMC were 
washed in fluorescence activated cell sorter (FACS) 
buffer (phosphate buffered saline (PBS) with 1 mmol/L 
EDTA and 0.02% sodium azide) and labelled on ice for 
20 minutes with monoclonal antibodies at predetermined 
optimal concentrations. Details of the specific antibodies 
(including clone and conjugated fluorochromes) can be 
found in Supplementary Table 1. Cells were then washed 
twice (450g, 5minutes) in FACS buffer and subsequently 
fixed with 1% paraformaldehyde (1% PFA). Cells were 
acquired within 48 hours on a FACS Canto-II flow 
cytometer (Becton-Dickinson, UK). Data analysis was 
carried out using WinlistTM software (Verity Software 
House, Maine, USA). The proportion of cells expressing 
any given surface marker of interest was determined by 
comparing fluorescence to that of an isotype-matched 
control antibody. Flow-count fluorospheresTM (Beckman 
Coulter, UK) were also added to all samples to determine 
absolute numbers. 
Cytokine analysis
Cytokine and chemokine levels of 40 different 
metabolites were determined in the serum samples using 
the multiplex immunoassay Bio-Plex Pro TM Human 
chemokine panel (BIO-RAD) on a Luminex MAGPIX 
system (Merck Millipore). Determined cytokines and their 
detection limits (following manufacturer´s instructions) 
are detailed in Supplementary Table 2.
Statistical analysis
Statistical analyses were carried out using GraphPad 
software (La Jolla-CA, USA). Pooled data are expressed 
as mean values +/- SEM. Non parametric tests (Mann 
Whitney Rank-sum tests and Pearson´s correlation 
analysis) were used and p < 0.05 was considered 
significant.
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